Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-004968

Chief Accounting Officer sold 25,000 shares at $29.18 ($729,570)

  • Chief Accounting Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2021-02-03 Option exercise +25,000 $8.27 $206,750 25,000 D
Lyon Joseph Douglas Chief Accounting Officer 2021-02-03 Sale −25,000 $29.18 $729,570 0 D
Derivatives
Lyon Joseph Douglas Chief Accounting Officer 2021-02-03 Option exercise · Stock Option (Right to Buy) −25,000 29,167 D
Open-market sales · 25,000 sh · avg $29.18 · $729,570
Loading xslF345X03/doc4.xml…